Urethral Bulking System Market

Urinary incontinence is a health issue experienced usually in women. In this condition the patient experience urine leakage due to pressure on urethra and bladder. Thus, frequent urination becomes a significant early symptom. 1 in 3 women at some point of time in their lives suffer from urinary incontinence. Aging increases the chances of urinary incontinence. Urethral incontinence is typically related with the economic burden and affect the quality of life. The treatment for urethral incontinence is usually surgery but with the growing advancement, the ureteral bulking systems has been proved as a better and advanced alternate to open surgery. These bulking systems help to resist the frequent urine flow. The bulking agents are injected in the periurethral wall and then solidifies to cover the wall of urethra, restricting the urine flow. Urethral bulking systems are usually made up of silicone beads, collagen, carbon particles, and polytetrafluoroethylene paste. Recently bulkamid, an injectable bulking agent has been proven effective for urethral incontinence.
Urethral Bulking System Market contains market size and forecasts of Urethral Bulking System in Global, including the following market information:
Global Urethral Bulking System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Urethral Bulking System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Endoscopic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urethral Bulking System include CR Bard, Merz Aesthetics, Cogentix Medical, Q-Med, ASCENTX MEDICAL, INC., Coloplast Corp., Boston Scientific Corporation and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urethral Bulking System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urethral Bulking System Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Urethral Bulking System Market Segment Percentages, by Type, 2021 (%)
Endoscopic
Non- Endoscopic
Global Urethral Bulking System Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Urethral Bulking System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Urethral Bulking System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Urethral Bulking System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urethral Bulking System revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Urethral Bulking System revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CR Bard
Merz Aesthetics
Cogentix Medical
Q-Med
ASCENTX MEDICAL, INC.
Coloplast Corp.
Boston Scientific Corporation
AstraZeneca